Literature DB >> 3882495

The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.

R I Fink, R R Revers, O G Kolterman, J M Olefsky.   

Abstract

Elevated basal and stimulated insulin levels have been previously demonstrated in elderly human subjects. To see whether these elevated insulin levels are due to alterations in either the metabolic clearance rate (MCR) for insulin or the feedback inhibition of insulin secretion, we have studied 14 elderly and 19 nonelderly subjects, mean age 70 +/- 2 and 35 +/- 2 yr, respectively. Fasting serum insulin and C-peptide levels were elevated in the elderly compared with the nonelderly, 17 +/- 2 versus 11 +/- 1 microU/ml, P less than 0.01 and 0.95 +/- 0.12 versus 0.47 +/- 0.07 pmol/ml, P less than 0.001. Euglycemic hyperinsulinemia created by insulin infusion rates of 15, 40, and 1200 mU/m2/min with glucose held constant resulted in steady-state serum insulin levels of 65 +/- 4, 109 +/- 8, and 11,316 +/- 890 versus 34 +/- 2, 96 +/- 5, and 11,083 +/- 1079 microU/ml in the elderly and nonelderly subjects, respectively. The MCR of insulin was decreased by 46% in the elderly compared with the nonelderly (10.1 +/- 0.7 versus 18.7 +/- 1.4 ml/kg/min) at the insulin infusion rate of 15 mU/m2/min with no difference observed between the two groups at the higher insulin infusions. Steady-state suppression of C-peptide by exogenous insulin was similar, 73 +/- 2% versus 72 +/- 2% and 70 +/- 3% versus 64 +/- 5% in the nonelderly and elderly groups during the 15 and 40 mU/m2/min insulin infusions, respectively. However, 50% suppression was achieved within 30 min in the nonelderly group compared with 70 min in the elderly group during the low-dose infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882495     DOI: 10.2337/diab.34.3.275

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  Mechanisms of age-related endocrine alterations. Part II.

Authors:  A D Mooradian
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 2.  Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus.

Authors:  C D Saudek; S Hill Golden
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

3.  Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors.

Authors:  I Lager; S Attvall; B M Eriksson; H von Schenk; U Smith
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

4.  Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.

Authors:  Aleksey V Matveyenko; Johannes D Veldhuis; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

5.  Weight loss therapy improves pancreatic endocrine function in obese older adults.

Authors:  Dennis T Villareal; Marian R Banks; Bruce W Patterson; Kenneth S Polonsky; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

Review 6.  Diabetes and altered glucose metabolism with aging.

Authors:  Rita Rastogi Kalyani; Josephine M Egan
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-22       Impact factor: 4.741

7.  Effects of aging on glucose-mediated glucose disposal and glucose transport.

Authors:  R I Fink; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  Pioglitazone is effective therapy for elderly patients with type 2 diabetes mellitus.

Authors:  Rukmini Rajagopalan; Alfonso Perez; Zhan Ye; Mehmood Khan; Frederick T Murray
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Practical strategies to normalize hyperglycemia without undue hypoglycemia in type 2 diabetes mellitus.

Authors:  Christopher T Kodl; Elizabeth R Seaquist
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

Review 10.  Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?

Authors:  Supriya Mathur; Nicola N Zammitt; Brian M Frier
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.